1. Comparison of Cell-Penetrating and Fusogenic TAT-HA2 Peptide Performance in Peptideplex, Multicomponent, and Conjugate siRNA Delivery Systems
   Metin Uz et al, 2024, ACS Omega CrossRef
2. Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia
   Shaghayegh Askarian Amiri et al, 2019, International Journal of Cancer Management CrossRef
3. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
   Dan Shu et al, 2015, ACS Nano CrossRef
4. In Vivo Delivery of siRNAs Targeting EGFR and BRD4 Expression by Peptide-Modified Redox Responsive PEG–PEI Nanoparticles for the Treatment of Triple-Negative Breast Cancer
   Xu Wan et al, 2021, Molecular Pharmaceutics CrossRef
5. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics
   Guruprasadh Swaminathan et al, 2021, Frontiers in Nanotechnology CrossRef
6. Innate and adaptive resistance to RNAi: a major challenge and hurdle to the development of double stranded RNA-based pesticides
   Chhavi Choudhary et al, 2021, 3 Biotech CrossRef
7. Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in-silico and in vitro studies
   Shaymaa A. Abdulmalek et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
8. Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors
   Jong Won Lee et al, 2023, ACS Omega CrossRef
9. Chemical Compositions and Anti-Proliferative Activity of the Aerial Parts and Rhizomes of Squirting Cucumber, Cucurbitaceae
   Ommoleila Molavi et al, 2019, Jundishapur Journal of Natural Pharmaceutical Products CrossRef
10. Targeted Delivery of BCL-2 siRNA Using Modified Ferritin Nanocarriers for Antitumor Therapy
    Li-Miao Qin et al, 2024, ACS Applied Nano Materials CrossRef
11. Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
    Ashutosh Gupta et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
12. Engineered NF-κB siRNA-encapsulating exosomes as a modality for therapy of skin lesions
    Wei Lu et al, 2023, Frontiers in Immunology CrossRef
13. Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines
    Manoj B. Parmar et al, 2015, Frontiers in Bioengineering and Biotechnology CrossRef
14. Potential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico Design
    Somayeh Shatizadeh Malekshahi et al, 2016, Jundishapur Journal of Microbiology CrossRef
15. Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
    Sanaz Naghizadeh et al, 2019, Current Medicinal Chemistry CrossRef
16. Reversing Multidrug-Resistant by RNA Interference Through Silencing MDR1 Gene in Human Hepatocellular Carcinoma Cells Subline Bel-7402/ADM
    Long Sheng et al, 2014, Pathology & Oncology Research CrossRef
17. Promising RNA-based therapies for Viral infections, Genetic Disorders and Cancer
    Dickson Achimugu Musa et al, 2024, Academia Molecular Biology and Genomics CrossRef